ChromaDex Corp. (Nasdaq: CDXC) announced that the U.S. Food and Drug Administration (FDA) has issued a generally recognized as safe ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA

U.S. FDA issues GRAS No Objection Letter for NIAGEN®August 15, 2016 6:30 AM ChromaDex (CDXC) Reports Q2 EPS of $0.00August 11, 2016 4:41 PM Form 8-K ChromaDex Corp. For: Aug 11August 11, 2016 4:16 PM ChromaDex Reports Record Revenue as Ingredients Sales Climb 83% Compared to Previous Year PeriodAugust 11, 2016 4:10 PM Form 10-Q ChromaDex Corp. For: Jul 02August 11, 2016 4:09 PM